On the readiness of physicians for pharmacogenomics testing: an empirical assessment.

Pharmacogenomics J

Cancer Genomics Laboratory, Department of Molecular Medicine, Centre de recherche du CHU de Québec-Université Laval, Québec, Québec, Canada.

Published: April 2018

This paper aims to explore the determinants of adoption of pharmacogenomics (PGx) testing by clinicians, and to assess whether this adoption differs with regard to area of specialization. Data were collected from a web-based survey among physicians in Québec (Canada). Our results highlighted that they perceived several benefits and had favorable attitudes toward PGx tests, but felt unprepared to use them. Results also show that practice specialties matter. Notably, being a family physician decreases the likelihood of adopting PGx tests. This might be explained by the fact that they perceived fewer benefits, used fewer sources of information, and received less training in PGx than their colleagues in other specialties. This is of particular concern given that family physicians are at the forefront of the healthcare system. Overcoming two knowledge barriers, that is, lack of information and clinical guidelines on PGx tests, might enhance physicians' readiness to adopt PGx testing.

Download full-text PDF

Source
http://dx.doi.org/10.1038/tpj.2017.22DOI Listing

Publication Analysis

Top Keywords

pgx tests
12
pgx testing
8
pgx
6
readiness physicians
4
physicians pharmacogenomics
4
pharmacogenomics testing
4
testing empirical
4
empirical assessment
4
assessment paper
4
paper aims
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!